<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Niluh Suwasanti</style></author><author><style face="normal" font="default" size="100%">Cecilia Putri Tedyanto</style></author><author><style face="normal" font="default" size="100%">Silvia Sutandhio</style></author><author><style face="normal" font="default" size="100%">Teguh Hari Sucipto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In Vitro Antiviral Activity of Dried Red Jujube Fruit (Ziziphus jujuba) Ethanol Extract against DENV-2</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">Dengue virus</style></keyword><keyword><style  face="normal" font="default" size="100%">DENV-2</style></keyword><keyword><style  face="normal" font="default" size="100%">dried red jujube fruit</style></keyword><keyword><style  face="normal" font="default" size="100%">Ziziphus jujuba</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1047-1050</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Dengue infection has become one of the most important mosquito-borne diseases worldwide and is caused by the dengue virus (DENV). Recently, neither patent drug, phytopharmaceutical medicine, nor standardized herbal medicine has been officially available against DENV. Dried red jujube fruit &lt;em&gt;(Ziziphus jujuba)&lt;/em&gt; ethanol extract has been proven to have an antiviral effect, anti-inflammatory efficacy, and antioxidant properties, which have potential activity against DENV infection. This research was conducted to analyze the antiviral activity of dried red jujube fruit ethanol extract against DENV-2 in vitro. The halfmaximal cytotoxic concentration (CC&lt;sub&gt;50&lt;/sub&gt;) and half-maximal inhibitory concentration (IC&lt;sub&gt;50&lt;/sub&gt;) were examined on Vero cells by a 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, whereas the halfmaximal effective concentration (EC&lt;sub&gt;50&lt;/sub&gt;) was determined using luminescence assay. The selectivity index (SI) value was determined from the ratio of CC&lt;sub&gt;50&lt;/sub&gt; and EC50. Dried red jujube fruit ethanol extracts inhibited DENV-2 in 24.59%, 22.39%, 17.98%, 14.5%, 6.42%, and 1.28% at 80 μg/mL, 40 μg/mL, 20 μg/mL, 10 μg/ mL, 5 μg/mL, and 2.5 μg/mL, respectively. The extract exhibited antiviral activity against DENV-2, showing a CC&lt;sub&gt;50&lt;/sub&gt; of 67.73 μg/mL, an IC&lt;sub&gt;50&lt;/sub&gt; value of 166.18 μg/mL, and an EC&lt;sub&gt;50&lt;/sub&gt; of 64.87 μg/mL, with an SI of 1.04. The LD&lt;sub&gt;50&lt;/sub&gt; value was 707.95 mg/kg. Dried red jujube fruit ethanol extract could be a potential candidate for developing an antiviral against DENV-2.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1047</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Niluh Suwasanti&lt;sup&gt;1&lt;/sup&gt;, Cecilia Putri Tedyanto&lt;sup&gt;2&lt;/sup&gt;, Silvia Sutandhio&lt;sup&gt;3&lt;/sup&gt;, Teguh Hari Sucipto&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Clinical Pathology, Faculty of Medicine, Universitas Katolik Widya Mandala Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Research Assistant, Faculty of Medicine, Universitas Katolik Widya Mandala Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Microbiology and Parasitology, Faculty of Medicine, Universitas Katolik Widya Mandala Surabaya, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Dengue Study Group, Institude of Tropical Disease, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Thi-Lien Nguyen</style></author><author><style face="normal" font="default" size="100%">Huong Ha Thi Thanh</style></author><author><style face="normal" font="default" size="100%">Kiet Ngo Tuan</style></author><author><style face="normal" font="default" size="100%">Doan Cao Son</style></author><author><style face="normal" font="default" size="100%">Thao Le Quang</style></author><author><style face="normal" font="default" size="100%">Hang Nguyen Thi</style></author><author><style face="normal" font="default" size="100%">Tien Vuong Duy</style></author><author><style face="normal" font="default" size="100%">Quyen Doan Thi Tam</style></author><author><style face="normal" font="default" size="100%">Huan Le Quang</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Antiviral Effects and Toxicity of Herbal Medicine Vipdervir Capsules</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">H5N1</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">SARS-CoV-2.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">681-689</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Antiviral vaccine is not effective, synthetic antiviral drugs are highly toxic, leading to increased interest in herbal medicines as promising antiviral drugs. Recently, Vipdervir has been developed from medicinal herbs with the aim to support and treat diseases caused by viruses such as H5N1 and SARSCoV- 2. In the present study, we assessed Vipdervir's antiviral activity against H5N1 and SARS-CoV-2. In addition, we also evaluated the acute toxicity and repeated dose toxicity of Vipdervir in mice and rabbits, respectively. &lt;strong&gt;Methods&lt;/strong&gt;: H5N1 inhibitory effect of Vipdervir was assessed using hemagglutination inhibition assay. Vipdervir's SARS-CoV-2 inhibitory effect was evaluated by Plaque Reduction Neutralization assay. Acute and repeated dose oral toxicities of Vipdervir were determined according to OECD 423 and OECD 407 guidelines, respectively. &lt;strong&gt;Results:&lt;/strong&gt; Data show that Vipdervir is effective against both H5N1 and SARSCoV- 2. At concentrations of 3 mg/mL and 5 mg/mL Vipdervir completely inhibits H5N1. At a concentration of 50 μg/mL Vipdervir showed an inhibitory effect on SARS-CoV-2. Acute toxicity data revealed that the LD50 of Vipdervir is greater than 35200 mg/kg, b.wt. in mice. Repeated toxicity data indicated that Vipdervir did not induce significant differences in body weight gain, hematology and clinical biochemistry in compared to the control group. The No Observed Adverse Effect Level of Vipdervir is greater than 613.8 mg/kg b.wt./day in rabbits. No delayed toxicity effects of Vipdervir were observed. &lt;strong&gt;Conclusion&lt;/strong&gt;: Vipdervir capsules were found to be antiviral effective and relatively safe in the tested doses and experimental conditions.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><accession-num><style face="normal" font="default" size="100%">27</style></accession-num><section><style face="normal" font="default" size="100%">681</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Thi-Lien Nguyen&lt;sup&gt;1,*&lt;/sup&gt;, Huong Ha Thi Thanh&lt;sup&gt;2&lt;/sup&gt;, Kiet Ngo Tuan&lt;sup&gt;3&lt;/sup&gt;, Doan Cao Son&lt;sup&gt;1&lt;/sup&gt;, Thao Le Quang&lt;sup&gt;1&lt;/sup&gt;, Hang Nguyen Thi&lt;sup&gt;1&lt;/sup&gt;, Tien Vuong Duy&lt;sup&gt;1&lt;/sup&gt;, Quyen Doan Thi Tam&lt;sup&gt;4&lt;/sup&gt;, Huan Le Quang&lt;sup&gt;5,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;National Institute of Drug Quality Control, 48-Hai Ba Trung st., Hoan Kiem dist., Ha Noi city, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet st., Cau Giay dist., Ha Noi city, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;University of Science and Technology of Hanoi, 18-Hoang Quoc Viet st., Cau Giay dist., Ha Noi city, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;High School for Gifted Students, Hanoi University of Science, 182- Luong The Vinh St., Thanh Xuan dist., Ha Noi city, VIETNAM.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Institute of Biotechnology, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet st., Cau Giay dist., Ha Noi city, VIETNAM.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Syaza Safia Fouzi</style></author><author><style face="normal" font="default" size="100%">Noor Zarina Abd Wahab</style></author><author><style face="normal" font="default" size="100%">Leong Chee Yan</style></author><author><style face="normal" font="default" size="100%">Nazlina Ibrahim</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Styrylpyrone Derivative from Goniothalamus sp.: A Powerful Drug for Fighting Against Herpes Simplex Virus Type 1</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">Herpes Virus type 1 (HSV-1)</style></keyword><keyword><style  face="normal" font="default" size="100%">in silico approaches</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular docking and Styrylpyrone derivative.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1598-1606</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;The emergence of drug resistance towards Herpes Simplex Virus Type 1 (HSV-1) has encouraged scientists to develop novel lower toxicity and highly effective anti-HSV drugs. Styrylpyrone derivative (SPD) is a bioactive compound isolated from the roots and leaves of Goniothalamus sp. It is believed that this compound possesses antiviral properties against HSV-1. &lt;strong&gt;Objective: &lt;/strong&gt;This paper introduces the interaction of SPD towards HSV-1 through in silico study of molecular docking and molecular dynamic simulation.&lt;strong&gt; Materials and Methods:&lt;/strong&gt; Molecular docking is a computational tool which is used to study the molecular interaction between two or more structures. ADME/T properties of the SPD were generated using the SwissADME online tool in which SPD was found to have a good pharmacokinetic profile. &lt;strong&gt;Results:&lt;/strong&gt; Molecular docking study revealed that SPD has a high docking score of -7.9 Kcal/mol. SPD has a strong affinity with the thymidine kinase (PDB id: 1OF1) producing hydrogen bond and non-polar interaction at the target point of amino acid residue. &lt;strong&gt;Conclusion:&lt;/strong&gt; Molecular docking analysis provides new insight into the structure-based design of SPD compounds with better antiviral activity against HSV-1.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1598</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Syaza Safia Fouzi&lt;sup&gt;1&lt;/sup&gt;, Noor Zarina Abd Wahab&lt;sup&gt;2&lt;/sup&gt;, Leong Chee Yan&lt;sup&gt;1&lt;/sup&gt;, Nazlina Ibrahim&lt;sup&gt;1&lt;/sup&gt;,*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biological Science and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, MALAYSIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, 21300 Kuala Nerus, Terengganu, MALAYSIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marissa Angelina</style></author><author><style face="normal" font="default" size="100%">Muhammad Hanafi</style></author><author><style face="normal" font="default" size="100%">Franciscus D Suyatna</style></author><author><style face="normal" font="default" size="100%">Beti Ernawati Dewi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug of Action Cassia Alata Leaves Extract as Antiviral to Dengue Virus Serotype-2 in vitro</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">Cassia alata</style></keyword><keyword><style  face="normal" font="default" size="100%">Dengue virus</style></keyword><keyword><style  face="normal" font="default" size="100%">Early step</style></keyword><keyword><style  face="normal" font="default" size="100%">Post infection</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">864-871</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background and Objectives: &lt;/strong&gt;Dengue viruses (DENV) is a mosquito-borne members of the Flaviridae family.To date, more than 2.5 billion people in over 100 countries are at risk of infection, and approximately 20 million infections were reported annually. Currently, There is no specific antiviral treatment available for DENV infection. Natural products possess a wide range of biological and biochemical potential. Among them, plants are one of the most important sources for discovering new drugs for therapy. Our previous study, showed that &lt;em&gt;Cassia alata&lt;/em&gt; has potency as antiviral to DENV, however drug of action still unclear. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; We explore the drug of action of C. alata leaves exract and its fraction through time of addition studies and effect of solvents wtih the dose based on the previous study. &lt;strong&gt;Results:&lt;/strong&gt; The most effective inhibition druf of action was determined by focus assay. Meanwhile the toxicity was measured by MTT assay. These studies demosntrated that ethanol extract of &lt;em&gt;Cassia alata&lt;/em&gt; 1 mg/ml showed strong inhibition in both early step (receptor and attachment to host cells) and post infection with inhibition 96.04 % and 99.16 %.Compared with those fractions, &lt;em&gt;Cassia alata&lt;/em&gt; ethanol extract has strongest inhibition DENV in every step of virus replication. &lt;strong&gt;Conclussion: &lt;/strong&gt;&lt;em&gt;Cassia alata&lt;/em&gt; ethanol extract has strongest inhibition DENV in every step of virus replication with the average of inhibition more than 95 %. Ethyl acetate and hexane has strongest inihibition with the average of inhibition 100 %.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">864</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Marissa Angelina&lt;sup&gt;1,2&lt;/sup&gt;, Muhammad Hanafi&lt;sup&gt;2&lt;/sup&gt;, Franciscus D. Suyatna&lt;sup&gt;3&lt;/sup&gt;, Beti Ernawati Dewi&lt;sup&gt;4,&lt;/sup&gt;* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Programme in Biomedical Science Faculty of Medicine, University of Indonesia, Jl. Salemba Raya 6, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Research Centre for Chemistry LIPI , Kompleks Puspiptek Serpong 15416, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacology and Therapeutics Faculty of Medicine- RSCM Universitas Indonesia, Jl. Salemba Raya 6, Jakarta 10430, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Departement of Microbiology Faculty of Medicine, Universitas Indonesia- Cipto Mangukusumo Hospital, Jalan Pengangsaan Timur No. 16 Jakarta 10320, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">María C. Flechas</style></author><author><style face="normal" font="default" size="100%">Raquel E. Ocazionez</style></author><author><style face="normal" font="default" size="100%">Elena E. Stashenko</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of in vitro Antiviral Activity of Essential Oil Compounds Against Dengue Virus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style  face="normal" font="default" size="100%">Dengue</style></keyword><keyword><style  face="normal" font="default" size="100%">Essential oil</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavivirus</style></keyword><keyword><style  face="normal" font="default" size="100%">Terpene</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/366</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">55-59</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; There are not effective drugs available for treatment of dengue fever despite intensive research on synthetic inhibitors. The search for active phytochemicals could serve for the discovery of new drugs. This study aims to evaluate the antiviral activity&lt;em&gt; in vitro&lt;/em&gt; of compounds found in essential oils from medicinal plants. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Nine synthetic-derived essential oil compounds were evaluated. Antiviral effect was screened measuring the reduction of viral NS1 and E proteins in HepG-2 and Vero cells. Results: &amp;beta;-Caryophyllene was identified as the most active compound, it reduced the virus serotype-2 replication in HepG-2 cells at IC&lt;sub&gt;50&lt;/sub&gt; of 22 &amp;plusmn; 5.6 &amp;mu;M, and blocked replication of all four serotypes in Vero cells at IC&lt;sub&gt;50&lt;/sub&gt; between 8.0 &amp;mu;M and 15.0 &amp;mu;M. The selectivity indexes were between 5.3 and 10. According to results from time-in-addition assays, the antiviral effect of &amp;beta;-caryophyllene appears to be associated with interruption of early steps of the virus life cycle. Citral revealed modest antiviral effect, it reduced the virus serotype-2 (IC&lt;sub&gt;50&lt;/sub&gt; of 31 &amp;plusmn; 4.5 &amp;mu;M) replication but not the other three serotypes. Seven terpenes did not reveal antiviral activity at maximum concentration of 30 &amp;mu;M. &lt;strong&gt;Conclusion:&lt;/strong&gt; Research on compounds found in essential oils can contribute to the drug discovery effort for dengue. &amp;beta;-Caryophyllene could serve as a starting point.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">55</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Mar&amp;iacute;a C. Flechas, Raquel E. Ocazionez*, Elena E. Stashenko &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Centro de Investigaciones en Enfermedades Tropicales (CINTROP) and Centro de Investigaci&amp;oacute;n en Biomol&amp;eacute;culas (CIBIMOL), Universidad Industrial de Santander, Bucaramanga, COLOMBIA.&lt;/p&gt;</style></auth-address></record></records></xml>